Article info

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Authors

  1. Correspondence to Dr Richard E Pratley; Richard.Pratley.MD{at}AdventHealth.com
View Full Text

Citation

Pratley RE, Jacob S, Baek S, et al
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Publication history

  • Received February 16, 2021
  • Accepted October 7, 2021
  • First published January 18, 2022.
Online issue publication 
January 18, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.